FDA

An article from the Coalition for Healthcare Communication discussed a recent webinar hosted by the Office of Prescription Drug…

After three years of work the Food and Drug Administration (FDA) released its final Risk Evaluation and Mitigation Strategies…

Over the past year, Congress has been extremely busy putting together User Fee Act legislation that will reauthorize the…

The Food and Drug Administration (FDA) recently published an Issue Paper discussing the use of surveys to assess whether a risk…

As we have noted over the past several months, drug shortages have been causing severe problems for patients in America.   Drug…

As we noted last month, former Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach, M.D., wrote an op-ed in the…

As explained in the Food and Drug Administration’s (FDA) mission statement, it is FDA’s responsibility to (1) promote the public…

There has been a tremendous amount of attention surrounding drug shortages in the U.S. over the past several months—and rightly…

In 2011, an Institute of Medicine report found that chronic pain affects 116 million Americans and costs the U.S. as…

On April 28, 2008, the Food and Drug Administration (FDA) amended its regulations on the acceptance of foreign clinical studies…